Concepedia

R.F. DeVore

RD

Statistics

Publications

9

Citations

307

H-Index

9

Active since

1992

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Vanderbilt-Ingram Cancer Center

Saint Thomas Health

R.F. DeVore is an author at Vanderbilt University specializing in lung cancer, oncology, and radiation oncology.

Top concepts

Publications per year

1992–2004

9

Publications

9

Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer

John V. Heymach, David H. Johnson, Fadlo R. Khuri et al. · Annals of Oncology · 2004 · 89 citations · Full text

, , +8

Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis.

Anita H. Corbett, R.F. DeVore, Neil Osheroff · Journal of Biological Chemistry · 1992 · 46 citations · Full text

, , +7

Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.

Madan Jagasia, Corey J. Langer, Douglas H. Johnson et al. · PubMed · 2001 · 41 citations

, , +14

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial

H. Choy, R.F. DeVore, Kenneth R. Hande et al. · Lung Cancer · 2001 · 36 citations

, , +5

A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbuilt Cancer Center Affiliate Network (VCCAN) Trial

H. Choy, R.F. DeVore, Kenneth R. Hande et al. · Clinical Lung Cancer · 2000 · 24 citations

, , +8

1–5 of 9